A YSPH alum and an employee of the U.S. Health Department, Agbenyikey has devoted his career to outcome-driven research and the pursuit of health care for all.
New research examines the role of KCC2, a transporter responsible for the discharge of chloride in cells, in developing disorders such as epilepsy and autism.
Researchers at Yale and around the globe are working tirelessly to save lives by advancing the science and practice of breast cancer treatment and prevention.
A therapy involving a synthetic RNA molecule called Stem Loop RNA 14, developed by Yale researchers, stimulates immune cells to shrink or kill tumors in mice.
Yale researchers have agreed to develop, deploy, and test a new device they hope will cut MRI costs and make the technology more widely available globally.
A simple walking test can evaluate the likelihood of functional decline in older adults following a heart attack, according to research led by Alexandra Hajduk.
The collaboration will aim to improve access to HIV testing, treatment, and care as part of the federal government’s Ending the HIV Epidemic initiative.
Yale cardiologist Dr. Harlan Krumholz discusses presidential candidate Bernie Sanders’ recent heart attack and advances in cardiac treatment and prognosis.
A new meta-analysis offers insight into which among the 35,000 annual intracerebral hemorrhage patients in Europe and America would most benefit from surgery.
